Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-21-032851

Options or other derivatives

  • Chief Medical Officer acquired 330,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Friend John E. II Chief Medical Officer 2021-03-04 Grant or award · Stock option (right to buy) +330,000 330,000 D
Loading xslF345X03/tm218888d1_4.xml…